NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ailurus Biotechnology

Ailurus Biotechnology

Private
LondonHealthcare & Life Scienceshttps://ailurus.bio/

Last Round

Angel

Oct 27, 2021

Total Funding Raised

$3.1M

Company Overview

Ailurus Biotechnology is a synthetic biology company that develops biocomputing platforms and automated workflows to streamline protein engineering and scientific discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Workflow Automation, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

synthetic biologybiocomputingprotein engineeringbiofoundryautomated biologymetabolic pathway engineeringprotein purificationsynthetic organellesbioprogramminghigh-throughput screeninglab automationAI-driven drug discoverybiotech R&D servicesbioengineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ailurus Biotechnology Comparables

Compare Ailurus Biotechnology with similar companies based on industry and business-model similarity.

Ailurus Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Ailurus Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelOct 27, 2021
AcceleratorOct 12, 2020

Ailurus Biotechnology Investors

Notable investors and investment history

Ailurus Biotechnology investors
InvestorRounds
GeniLink CapitalAngel
5Y CapitalAngel
MiraclePlusAccelerator, Angel

Ailurus Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ailurus Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ailurus Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range17
Year Founded2022
Last FundingOct 27, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.